Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Emilia, Caverly"'
Autor:
Daniel FP Larkin, Kashfia Chowdhury, Caroline J Doré, Catey Bunce, Jennifer M Burr, Emilia Caverly, Lisa French, Dimitra Kopsini, Anne Klepacz, Mathew Raynor, Matthew Edwards, Stephen J Tuft
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 8, Iss 15 (2021)
Background: Keratoconus is a disease of the cornea affecting vision that is usually first diagnosed in the first three decades. The abnormality of corneal shape and thickness tends to progress until the patient reaches approximately 30 years of age.
Externí odkaz:
https://doaj.org/article/4faf3d91f14c4cbb879595ccf1e1e94d
Autor:
Richard Gilson, Diarmuid Nugent, Kate Bennett, Caroline J Doré, Macey L Murray, Jade Meadows, Lewis J Haddow, Charles Lacey, Frank Sandmann, Mark Jit, Kate Soldan, Michelle Tetlow, Emilia Caverly, Mayura Nathan, Andrew J Copas
Publikováno v:
Health Technology Assessment, Vol 24, Iss 47 (2020)
Background: The comparative efficacy, and cost-effectiveness, of imiquimod or podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine (Gardasil®, Merck Sharp & Dohme Corp., Merck & Co., Inc., Whitehouse Station, NJ, U
Externí odkaz:
https://doaj.org/article/3ca84eeeca9748d3ba51cac0da838823
Autor:
Daniel F.P. Larkin, Kashfia Chowdhury, Jennifer M. Burr, Mathew Raynor, Matthew Edwards, Stephen J. Tuft, Catey Bunce, Emilia Caverly, Caroline Doré, Susmito Biswas, Jennifer Burr, Lisa French, Stephen Kaye, Anne Klepacz, Dimitra Kopsini, Frank Larkin, Stephen Tuft, Sue Webber, Colin Willoughbys
Publikováno v:
Ophthalmology. 128:1516-1526
Purpose To examine the efficacy and safety of corneal cross-linking (CXL) for stabilization of progressive keratoconus. Design Observer-masked, randomized, controlled, parallel-group superiority trial. Participants Sixty participants 10 to 16 years o
Autor:
Caroline J Doré, Stephen J Tuft, Catey Bunce, Kashfia Chowdhury, Daniel Fp Larkin, Mathew Raynor, Emilia Caverly, Anne Klepacz, Dimitra Kopsini, Jennifer Burr, Matthew Edwards, Lisa French
Publikováno v:
Efficacy and Mechanism Evaluation, Vol 8, Iss 15 (2021)
Background Keratoconus is a disease of the cornea affecting vision that is usually first diagnosed in the first three decades. The abnormality of corneal shape and thickness tends to progress until the patient reaches approximately 30 years of age. E
Autor:
Jonathan G, Best, Liz, Arram, Norin, Ahmed, Maryam, Balogun, Kate, Bennett, Ekaterina, Bordea, Marta G, Campos, Emilia, Caverly, Marisa, Chau, Hannah, Cohen, Hakim-Moulay, Dehbi, Caroline J, Doré, Stefan T, Engelter, Robert, Fenner, Nick, Freemantle, Rachael, Hunter, Martin, James, Gregory Yh, Lip, Macey L, Murray, Bo, Norrving, Nikola, Sprigg, Roland, Veltkamp, Iwona, Zaczyk, David J, Werring
Publikováno v:
Best, J G, Arram, L, Ahmed, N, Balogun, M, Bennett, K, Bordea, E, Campos, M G, Caverly, E, Chau, M, Cohen, H, Dehbi, H-M, Doré, C J, Engelter, S T, Fenner, R, Freemantle, N, Hunter, R, James, M, Lip, G YH, Murray, M L, Norrving, B, Sprigg, N, Veltkamp, R, Zaczyk, I, Werring, D J & OPTIMAS investigators 2022, ' Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS) : Protocol for a randomized controlled trial ', International Journal of Stroke, vol. 17, no. 5, pp. 583-589 . https://doi.org/10.1177/17474930211057722
Rationale Atrial fibrillation causes one-fifth of ischemic strokes, with a high risk of early recurrence. Although long-term anticoagulation is highly effective for stroke prevention in atrial fibrillation, initiation after stroke is usually delayed
Autor:
Daniel F P, Larkin, Kashfia, Chowdhury, Jennifer M, Burr, Mathew, Raynor, Matthew, Edwards, Stephen J, Tuft, Catey, Bunce, Emilia, Caverly, Caroline, Doré, Colin, Willoughbys
Supported by the National Institute for Health Research (NIHR ) Efficacy and Mechanism Evaluation Programme (grant no.: 14/23/18), a Medical Research Council and NIHR partnership. It was coordinated by University College London’s Comprehensive Clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8917d9bcd401c44844dbf7a7c0a1daae
https://hdl.handle.net/10023/24399
https://hdl.handle.net/10023/24399
Autor:
Frank Sandmann, Richard Gilson, Macey L. Murray, Mark Jit, Kate Soldan, Caroline J Doré, Charles J.N. Lacey, Kate Bennett, Michelle Tetlow, Jade Meadows, Andrew Copas, Diarmuid Nugent, Emilia Caverly, Mayura Nathan, Lewis J. Haddow
Publikováno v:
Health Technol Assess
Health Technology Assessment, Vol 24, Iss 47 (2020)
Health Technology Assessment, Vol 24, Iss 47 (2020)
Background The comparative efficacy, and cost-effectiveness, of imiquimod or podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine (Gardasil®, Merck Sharp & Dohme Corp., Merck & Co., Inc., Whitehouse Station, NJ, US
Autor:
Felicia Ikeji, Michael R. Ehrenstein, Caroline Gordon, Emilia Caverly, Caroline J Doré, Kashfia Chowdhury, Alexis Jones, Patrick Muller, David A. Isenberg
Publikováno v:
BMJ Open
IntroductionFew treatment options exist for patients with systemic lupus erythematosus (SLE) who fail conventional therapy. Although widely used to treat lupus, the efficacy of B cell depletion therapy using rituximab has not been demonstrated in ran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80465b8cdc1ff9fd6fadf05b79839685
Autor:
Frank Sandmann, Richard Gilson, Macey L. Murray, Kate Bennett, Charles J.N. Lacey, Mayura Nathan, Mark Jit, Lewis J. Haddow, Diarmuid Nugent, Emilia Caverly, Kate Soldan, Andrew Copas, Caroline J Doré
Publikováno v:
Oral Presentations.
Background The comparative efficacy, and cost-effectiveness, of imiquimod (IMIQ) or podophyllotoxin (PDX) cream, either alone or in combination with the quadrivalent HPV vaccine (Gardasil®, Merck) in the treatment and prevention of recurrence of ano